DK1131094T3 - Multivalent T.d.Poliovaccine mod mindst difteri, poliomyelitis og tetanus - Google Patents

Multivalent T.d.Poliovaccine mod mindst difteri, poliomyelitis og tetanus

Info

Publication number
DK1131094T3
DK1131094T3 DK99972544T DK99972544T DK1131094T3 DK 1131094 T3 DK1131094 T3 DK 1131094T3 DK 99972544 T DK99972544 T DK 99972544T DK 99972544 T DK99972544 T DK 99972544T DK 1131094 T3 DK1131094 T3 DK 1131094T3
Authority
DK
Denmark
Prior art keywords
vaccine
diphtheria
poliovaccine
poliomyelitis
tetanus
Prior art date
Application number
DK99972544T
Other languages
Danish (da)
English (en)
Inventor
Jean Rene Cartier
Patrick Laroche
Original Assignee
Aventis Pasteur Msd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8233032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1131094(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pasteur Msd filed Critical Aventis Pasteur Msd
Application granted granted Critical
Publication of DK1131094T3 publication Critical patent/DK1131094T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99972544T 1998-11-26 1999-11-25 Multivalent T.d.Poliovaccine mod mindst difteri, poliomyelitis og tetanus DK1131094T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98122373A EP1004314A1 (de) 1998-11-26 1998-11-26 T.d.Polio Impstoff für einer primovakzinierter oder empfindlicher Population
EP99972544A EP1131094B1 (de) 1998-11-26 1999-11-25 T.d.polio vielwertiger impstoff gegen mindestens diphterie, poliomyelitis und tetanus

Publications (1)

Publication Number Publication Date
DK1131094T3 true DK1131094T3 (da) 2005-02-14

Family

ID=8233032

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99972544T DK1131094T3 (da) 1998-11-26 1999-11-25 Multivalent T.d.Poliovaccine mod mindst difteri, poliomyelitis og tetanus

Country Status (14)

Country Link
EP (2) EP1004314A1 (de)
JP (1) JP2003525858A (de)
AT (1) ATE281176T1 (de)
AU (1) AU759221B2 (de)
CA (1) CA2352617A1 (de)
CZ (1) CZ20011860A3 (de)
DE (1) DE69921682T2 (de)
DK (1) DK1131094T3 (de)
ES (1) ES2228175T3 (de)
NZ (1) NZ511933A (de)
PL (1) PL347719A1 (de)
PT (1) PT1131094E (de)
WO (1) WO2000030678A1 (de)
ZA (1) ZA200103634B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0616306D0 (en) * 2006-08-16 2006-09-27 Novartis Ag Vaccines
WO2008028957A2 (en) * 2006-09-07 2008-03-13 Glaxosmithkline Biologicals S.A. Vaccine
CN111032078A (zh) 2017-07-18 2020-04-17 血清研究所印度私人有限公司 具有改善的稳定性、增强的免疫原性和降低的反应原性的免疫原性组合物及其制备方法
JOP20190242A1 (ar) 2018-10-12 2020-04-12 Serum Institute Of India Pvt Ltd تركيبة لقاح توليفي تشمل فيروس شلل الأطفال ذو جرعة مخفّضة خاملة التنشيط وطريقة لتحضيرها

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199802783T2 (xx) * 1996-07-02 1999-03-22 Connaught Laboratories Limited �ok de�erli DTP polyo a��lar.
GB9623233D0 (en) * 1996-11-07 1997-01-08 Smithkline Beecham Biolog Vaccine composition
DE69735191T2 (de) * 1997-09-15 2006-10-05 Sanofi Pasteur Msd Verfahren zur Herstellung multivalenter Impfstoffe
GB9806456D0 (en) * 1998-03-25 1998-05-27 Smithkline Beecham Biolog Vaccine composition

Also Published As

Publication number Publication date
PT1131094E (pt) 2005-02-28
PL347719A1 (en) 2002-04-22
DE69921682T2 (de) 2005-11-03
ZA200103634B (en) 2002-05-06
AU1390100A (en) 2000-06-13
EP1131094B1 (de) 2004-11-03
CA2352617A1 (en) 2000-06-02
ES2228175T3 (es) 2005-04-01
EP1131094A1 (de) 2001-09-12
EP1004314A1 (de) 2000-05-31
DE69921682D1 (de) 2004-12-09
JP2003525858A (ja) 2003-09-02
ATE281176T1 (de) 2004-11-15
AU759221B2 (en) 2003-04-10
CZ20011860A3 (cs) 2002-01-16
NZ511933A (en) 2002-09-27
WO2000030678A1 (fr) 2000-06-02

Similar Documents

Publication Publication Date Title
EA200501070A1 (ru) Поливалентная вакцинная композиция
NZ513202A (en) Antigen composition comprising Bordetella bronchiseptica, formalin and glutaraldehyde
DK0865297T3 (da) Vaccinesammensætninger til intranasal administration omfattende chitosan og anvendelsen deraf
ES2180651T3 (es) Vacuna que contiene acidos nucleicos.
DK0654086T3 (da) Vacciner mod Aujeszky's sygdom og andre dyresygdomme indeholdende mutanter af pseudo-rabies-virus
DK1047784T3 (da) Neissera meningitidis-antigener
BR9813930A (pt) antìgeno neisserial
BR9814483A (pt) "vacina"
CY1106206T1 (el) Φαρμακευτικη συνθεση πepιεχουσα φενοφιβρατη και μεθοδος παρασκευης της
DE122010000042I1 (de) Solubilisierung von capsulären Polysacchariden
BR0206293A (pt) Composições de imunização e métodos de uso
DK0988862T3 (da) Formulering indeholdende et antigen, en TH-1 inducerende adjuvant og en sparsomt vandoplöselig aminosyre til brug ved immunisering
CY1108526T1 (el) Εμβολια εναντι καρκινων
ATE244578T1 (de) Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit
FR2663130B1 (fr) Dispositif d'exposition par projection.
ATE377428T1 (de) Rotavirus-impfstoff
DK1131094T3 (da) Multivalent T.d.Poliovaccine mod mindst difteri, poliomyelitis og tetanus
ES2143666T3 (es) P-amidinobencilamidas dipeptidicas con restos sulfonilo, o bien aminosulfonilo n-terminales.
DK0387821T3 (da) 2-Alkyl-4-arylmethylchinoliner, deres anvendelse og lægemidler fremstillet hermed
DK0497121T3 (da) Hidtil ukendte tetrazolderivater, fremgangsmåde til fremstilling af disse og anvendelsen af disse
DK1015026T3 (da) IL-12 som en adjuvans til Bordetella pertussis-vacciner
NL300336I2 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
CY1105338T1 (el) Διαδικασια για την παρασκευη δισκοδepμολιδης και αναλογων αυτης
DK0721782T3 (da) Influenzavaccine indeholdende pertussistoksin
DE69708779D1 (de) Aufhänge- und Klemmsystem